Exact Sciences kicks off multi-cancer detection study

The first patient has joined Exact Sciences‘ registrational multi-cancer early detection (MCED) Falcon registry real-world evidence (RWE) study.

The multi-site study aims to enrol up to 25,000 participants aged 50-80 with no history of cancer, who will participate in annual MCED testing for three years and two additional years of follow-up data collection. The study will evaluate the clinical performance, patient and provider experience, and psychological impact of MCED testing over five years.